Johnson & Johnson buy Raymond James
Start price
03.01.24
/
50%
€147.60
Target price
03.01.25
€160.34
Performance (%)
-7.22%
Price
16:32
€135.84
Summary
This prediction is currently active. With a performance of -7.22%, the BUY prediction for Johnson & Johnson by Raymond_James is down slightly. A total of €1.10 was paid as dividends for this prediction. This prediction currently runs until 03.01.25. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Johnson & Johnson | -2.157% | -2.157% |
| iShares Core DAX® | 0.961% | -2.210% |
| iShares Nasdaq 100 | 2.626% | -1.918% |
| iShares Nikkei 225® | 0.217% | -7.216% |
| iShares S&P 500 | 1.540% | -1.858% |
Comments by Raymond_James for this prediction
In the thread Johnson & Johnson diskutieren
Johnson & Johnson (NYSE: JNJ) had its price target raised by analysts at Raymond James from $172.00 to $175.00. They now have an "outperform" rating on the stock.
Ratings data for JNJ provided by MarketBeat